(Q33892586)

29 July 2017

title

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States (English)

1 reference

29 July 2017

1 reference

1 reference

chronic liver disease

0 references

1 reference

1 reference

3

McQuillan GM

1 reference

29 July 2017

Armstrong GL

1

1 reference

29 July 2017

Alter MJ

series ordinal

2

1 reference

29 July 2017

Margolis HS

series ordinal

4

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

language of work or name

0 references

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

777-782

1 reference

Antibody to hepatitis C virus in post-transfusion hepatitis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

The natural history of hepatitis C-A quandary

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Hepatitis C: The clinical spectrum of disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Long-term persistence of hepatitis C virus antibodies in a single source outbreak

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Diagnostic tests for hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Methods must match the mission

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Causes of death in injection-drug users

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Mortality among injection drug users identified as "out of treatment"

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310332

7 January 2021

Identifiers

DOI

10.1002/HEP.510310332

1 reference

29 July 2017

1 reference